Safety of Cardiac Pacemakers in 3 Tesla MRI
|ClinicalTrials.gov Identifier: NCT00356330|
Recruitment Status : Unknown
Verified April 2007 by University Hospital, Bonn.
Recruitment status was: Recruiting
First Posted : July 26, 2006
Last Update Posted : April 11, 2007
|Condition or disease|
Recently, a shift could be observed from cardiac pacemakers being an absolute contraindication to being a relative contraindication for MR imaging at 1.5 Tesla, depending on a patient-per-patient risk-benefit-evaluation, which includes an urgent clinical need for MR imaging (other imaging modalities non-conclusive) and co-morbidities (especially cardiac co-morbidities). At the same time, MR imaging at 3 Tesla is evolving from a research application only to an important imaging modality today.
Using the improved signal-to-noise-ratio, high field MR-Systems with a field strength of 3 Tesla offer a variety of diagnostic advantages to 1.5 Tesla systems. These advantages lead to a higher sensitivity and specificity in diagnosing, foremost neurological, disorders.
In this study, we evaluate the safety of MR imaging of the brain in patients with cardiac pacemakers at 3T.
|Study Type :||Observational|
|Estimated Enrollment :||75 participants|
|Observational Model:||Defined Population|
|Observational Model:||Natural History|
|Official Title:||Study to Evaluate Safety of Cardiac Pacemakers in MR Imaging at 3T Tesla|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00356330
|Contact: Torsten Sommer, MDfirstname.lastname@example.org|
|Contact: Claas P Naehle, MDemail@example.com|
|University of Bonn, Department of Radiology||Recruiting|
|Bonn, NRW, Germany, 53127|
|Contact: Torsten Sommer, MD +49-163-7113875 firstname.lastname@example.org|
|Contact: Claas P Naehle, MD +49-178-4001619 email@example.com|
|Principal Investigator:||Torsten Sommer, MD||University of Bonn, Department of Radiology|